Anthem Biosciences Limited (BOM:544449)
India · Delayed Price · Currency is INR 755.35
-4.75 (-0.62%)
At close: Jun 1, 2026
Anthem Biosciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 5,918 | 4,513 | 3,673 | 3,852 | 4,055 |
Depreciation & Amortization | 1,341 | 893.71 | 818.24 | 637.74 | 578.35 |
Other Amortization | - | 0.78 | 0.78 | 0.78 | - |
Loss (Gain) From Sale of Assets | 0.28 | 4.37 | 4.29 | -0.53 | 1.65 |
Loss (Gain) From Sale of Investments | -48.86 | - | - | - | - |
Stock-Based Compensation | 158.59 | 343.46 | - | - | - |
Provision & Write-off of Bad Debts | 5.73 | 20.2 | - | - | - |
Other Operating Activities | -323.7 | -68.05 | -474.93 | -393.69 | 82.75 |
Change in Accounts Receivable | -1,261 | 330.46 | -2,164 | 521.31 | -715.29 |
Change in Inventory | 2,159 | -1,291 | -819.31 | -711.86 | -231.67 |
Change in Accounts Payable | -348.7 | 93.75 | 288 | 71 | -120.84 |
Change in Other Net Operating Assets | 844.91 | -657.05 | 75.13 | -916.75 | -321.21 |
Operating Cash Flow | 8,445 | 4,183 | 1,402 | 3,060 | 3,329 |
Operating Cash Flow Growth | 101.87% | 198.49% | -54.20% | -8.09% | 19.91% |
Capital Expenditures | -2,112 | -3,145 | -2,900 | -1,889 | -1,558 |
Sale of Property, Plant & Equipment | 37.72 | 22.75 | 6.91 | 0.7 | 0.55 |
Sale (Purchase) of Intangibles | - | -1.4 | -8.55 | -56.17 | -31.39 |
Investment in Securities | -5,695 | 385.54 | 274.07 | -2,262 | -637.06 |
Other Investing Activities | 752.82 | 1,217 | 413.38 | 446.62 | 171.48 |
Investing Cash Flow | -7,016 | -1,521 | -2,215 | -3,760 | -2,055 |
Short-Term Debt Issued | - | - | 919.91 | - | - |
Long-Term Debt Issued | - | - | 154.7 | 902.9 | - |
Total Debt Issued | - | - | 1,075 | 902.9 | - |
Short-Term Debt Repaid | -385.93 | -589.41 | - | -7.16 | -506.97 |
Long-Term Debt Repaid | -208 | -648.66 | - | - | -138.23 |
Total Debt Repaid | -593.93 | -1,238 | - | -7.16 | -645.2 |
Net Debt Issued (Repaid) | -593.93 | -1,238 | 1,075 | 895.74 | -645.2 |
Issuance of Common Stock | 265.65 | - | - | - | 2,475 |
Repurchase of Common Stock | - | - | -1,831 | - | - |
Preferred Dividends Paid | - | - | - | - | -0.01 |
Dividends Paid | - | - | - | - | -0.01 |
Other Financing Activities | -71.7 | -97.92 | -15.19 | -256 | -23.03 |
Financing Cash Flow | -399.98 | -1,336 | -771.81 | 639.74 | 1,807 |
Foreign Exchange Rate Adjustments | -2.71 | - | - | - | - |
Miscellaneous Cash Flow Adjustments | 0.01 | - | - | 0.01 | - |
Net Cash Flow | 1,026 | 1,326 | -1,585 | -60.56 | 3,081 |
Free Cash Flow | 6,333 | 1,038 | -1,499 | 1,171 | 1,771 |
Free Cash Flow Growth | 510.09% | - | - | -33.91% | 9.44% |
Free Cash Flow Margin | 29.81% | 5.61% | -10.55% | 11.06% | 14.27% |
Free Cash Flow Per Share | 11.16 | 1.85 | -2.64 | 2.05 | 3.10 |
Cash Interest Paid | 68.94 | 96.73 | 95.36 | 66.85 | 100.86 |
Cash Income Tax Paid | 2,040 | 1,590 | 1,200 | 1,150 | 1,230 |
Levered Free Cash Flow | 5,512 | 512.86 | -2,186 | 305.5 | 963.49 |
Unlevered Free Cash Flow | 5,555 | 574.68 | -2,129 | 355.97 | 1,036 |
Change in Working Capital | 1,394 | -1,524 | -2,620 | -1,036 | -1,389 |